Pouch

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

The patent file contains at least one drawing executed in color. Copies of this patent with color drawings will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 is a front perspective view of a pouch showing our new design according to a first embodiment;

FIG. 2 is a front elevation view thereof;

FIG. 3 is a rear elevation view thereof;

FIG. 4 is a left side elevation view thereof;

FIG. 5 is a right side elevation view thereof;

FIG. 6 is a top plan view thereof;

FIG. 7 is a bottom plan view thereof;

FIG. 8 is a front perspective view of a pouch showing our new design according to a second embodiment;

FIG. 9 is a front elevation view thereof;

FIG. 10 is a rear elevation view thereof;

FIG. 11 is a left side elevation view thereof;

FIG. 12 is a right side elevation view thereof;

FIG. 13 is a top plan view thereof; and,

FIG. 14 is a bottom plan view thereof.

The dash-dot broken lines in the figures illustrated claimed perforations. The remaining evenly-spaced dashed broken lines in the figures illustrate portions of the pouch that form no part of the claimed design.

Claims

The ornamental design for a pouch, as shown and described.

Referenced Cited
U.S. Patent Documents
D306555 March 13, 1990 Lane
D360578 July 25, 1995 Dees
D558593 January 1, 2008 Kienemund-Paroll
D682708 May 21, 2013 Smart
D706138 June 3, 2014 Arai
D880286 April 7, 2020 Lyle
D1008038 December 19, 2023 Baek
D1028736 May 28, 2024 Lee
Foreign Patent Documents
WO-D227870-001 February 2024 WO
WO-D227870-002 February 2024 WO
WO-D227870-003 February 2024 WO
WO-D227870-004 February 2024 WO
WO-D227870-005 February 2024 WO
WO-D227870-006 February 2024 WO
WO-D227870-007 February 2024 WO
Other references
  • Sunlenca Prescribing Information, posted Oct. 5, 2023 [retrieved Jul. 8, 2024]. Retrieved from internet, https://www.drugs.com/pro/sunlenca.html (Year: 2023).
  • Sunlenca for the Treatment of HIV-1 Infection, posted Jan. 11, 2023 [retrieved Jul. 8, 2024]. Retrieved from internet, https://www.clinicaltrialsarena.com/projects/sunlenca-lenacapavir-hiv-1/?cf-view (Year: 2023).
  • Briefly | Jan. + Feb. 2023, posted Apr. 25, 2023 [retrieved Jul. 8, 2024]. Retrieved from internet, https://www.positivelyaware.com/articles/briefly-january-february-2023 (Year: 2023).
  • Danilo Bacic Lima, posted Sep. 5, 2023 [retrieved Jul. 8, 2024]. Retrieved from internet, https://x.com/danbacic/status/1699170104590635297 (Year: 2023).
Patent History
Patent number: D1085889
Type: Grant
Filed: Aug 23, 2022
Date of Patent: Jul 29, 2025
Assignee: GILEAD SCIENCES, INC. (Foster City, CA)
Inventors: Charles Aldridge (Overland Park, KS), Robert S. Bridges (Foster City, CA), Gerald E. Coamey, Jr. (Chicago, IL), Jennifer Diaz Tonos (Chicago, IL), Anneke Druyts (Foster City, CA), Margaret Holland (Overland Park, KS), Michael O'Grady (Foster City, CA), Marc Brumagne (Foster City, CA), Brian Carlson (Foster City, CA), Joseph Cordova (Foster City, CA)
Primary Examiner: Darcey E Gottschalk
Assistant Examiner: Haley K Schnebele
Application Number: 29/850,826
Classifications
Current U.S. Class: D9/710